论文部分内容阅读
目的:对抗纤保肝汤治疗慢性乙型肝炎肝纤维化的临床效果进行研究与分析。方法:选取于2015年1月至2016年1月于本院接受治疗的慢性乙型肝炎患者158例,将其分为对照组与观察组两组,其中包含102例观察组患者以及156例对照组患者,为对照组患者提供常规治疗,为观察组患者提供保肝抗纤合剂药物治疗。结果:观察组患者在治疗总有效率方面明显优于对照组患者,各项检测指标均优于对照组,P<0.05差异有统计学意义。结论:为慢性乙型肝炎肝纤维化患者提供抗纤保肝汤药物治疗,能够有效改善患者的治疗效果,提高治疗有效率,临床价值值得推广。
OBJECTIVE: To study and analyze the clinical effect of “Fibao Baogan Decoction” in treating chronic hepatitis B liver fibrosis. Methods: A total of 158 patients with chronic hepatitis B who were treated in our hospital from January 2015 to January 2016 were divided into control group and observation group, including 102 patients in observation group and 156 patients in control group Patients in the control group received routine treatment and patients in the observation group received anti-liver fibrosis therapy. Results: The observation group was significantly better than the control group in the total effective rate of treatment, and the detection indexes were better than the control group, the difference was statistically significant (P <0.05). Conclusion: It is worth to popularize the anti-fibanguistic-hepatoprotective drug treatment for chronic hepatitis B patients with liver fibrosis that can effectively improve the treatment effect and improve the treatment efficiency.